Navigation Links
Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
Date:6/7/2008

and blood pressure levels improved. Systolic blood pressure decreased from baseline to endpoint by -3.7+/-1.2 mm Hg in the 5 mcg exenatide group (P=0.037; vs placebo) and also -3.7+/-1.2 mm Hg in the 10 mcg exenatide group (P=0.037; vs placebo), compared with -0.3+/-1.2 mm Hg for placebo (means +/- SEM). Diastolic blood pressure decreased from baseline to endpoint by -0.8+/-0.7 mm Hg in the 5 mcg exenatide group (P=0.619; vs placebo) and -2.3+/-0.7 mm Hg in the 10 mcg exenatide group (P=0.046; vs placebo), compared with -0.3+/-0.7 mm Hg for placebo (means +/- SEM).

There was an incidence of reported nausea in both the 5 mcg and 10 mcg arms of 3 and 13 percent, respectively, which is a lower incidence than what was observed in previous studies, where exenatide has been used in combination with other diabetes therapies. There were no instances of severe hypoglycemia. The overall incidence of hypoglycemia was similar to that seen in studies where exenatide was used in conjunction with metformin only.

Study Population

The 24-week, randomized study included 232 patients with type 2 diabetes who were not achieving adequate glucose control using diet and exercise without previous use of antidiabetes agents. Study participants were randomized to receive subcutaneous injections of placebo, 5 mcg exenatide, or 10 mcg exenatide twice daily without taking any oral antidiabetes agents. Patients randomized to 10 mcg exenatide received 5 mcg injections for the first four weeks, and increased to 10 mcg injections for the final 20 weeks.

About BYETTA(R) (exenatide) injection

BYETTA is the first and only FDA-approved incretin mimetic for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the FDA for use by peop
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
2. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
3. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
4. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
5. New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
6. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
9. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
10. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
11. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Mass. , April 24, 2015  Blueprint ... BLU-554, a selective and potent inhibitor of fibroblast ... activity in models of hepatocellular carcinoma (HCC) that ... therapeutic candidate, BLU-554 induced complete tumor regression in ... an FGFR4-activating ligand at the highest dose levels. ...
(Date:4/23/2015)...  ResMed Inc. (NYSE: RMD ) today announced ... for the quarter was $422.5 million, a 6 percent ... (a 13 percent increase on a constant currency basis).  ... percent compared to the quarter ended March 31, 2014.  ... an increase of 2 percent compared to the quarter ...
(Date:4/23/2015)... , April 23, 2015  Jazz Pharmaceuticals plc ... report its 2015 first quarter financial results on Thursday, ... markets.  Company management will host a live audio webcast ... IST to discuss first quarter 2015 financial results and ... parties may access the live audio webcast via the ...
Breaking Medicine Technology:Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2
... 2011 In a clear victory for consumers and ... the state,s costly law mandating fiduciary-disclosure requirements on pharmacy ... into a mandated state-prescribed contract model for pharmacy benefits ... terms between PBMs and their health plan and employer ...
... 29, 2011 Cellectis (Alternext: ALCLS), the French ... a collaboration agreement with Pregenen, an American biotechnology ... tools for genome engineering. Pregenen ... Consortium, a group that brings in renowned international ...
Cached Medicine Technology:Win for Consumers and Payers: Maine Repeals Costly PBM Fiduciary-Disclosure Law 2Cellectis and Pregenen Sign Collaboration Agreement for the Development of Meganucleases 2
(Date:4/26/2015)... In an article published last month ... head-neck biomechanics occurring during the use of handheld electronic devices ... determine that use of a tablet increases mechanical demand on ... - more than when the neck is in a neutral ... but pointing out the potential hazards of overuse of mobile ...
(Date:4/25/2015)... 26, 2015 Diversified Communications has ... healthcare event. The Integrative Healthcare Symposium Canada, as ... 2015 at the Sheraton Parkway Toronto North in ... one of the most anticipated events of the ... CME program. The event aims to gather multi-disciplined ...
(Date:4/25/2015)... York, New York (PRWEB) April 25, 2015 ... ) established for vaginal mesh lawsuits filed against ... the U.S. District Court, Southern District of West ... 9th, a Scheduling Conference was convened that day, ... Plaintiffs’ Master Long Form Complaint. The Order directed ...
(Date:4/25/2015)... Gardant Management Solutions will lead sessions ... and sales and marketing at the LeadingAge Illinois ... held from April 29 through May 1 in ... eldercare association in Illinois. The statewide association represents ... including senior housing, assisted living and supportive living ...
(Date:4/25/2015)... Minneapolis, Minnesota (PRWEB) April 25, 2015 For ... as the premier income protection education event in the nation! ... up with The Plus Group, US to take DI Day ... Day. , George G. Davidson, CLU, ChFC, RHU, DIA, CLTC, ... Twin Cities DI Day reflects on the change by stating, ...
Breaking Medicine News(10 mins):Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Integrative Healthcare Event launching in Canada 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Secura Consultants Takes DI Day On The Road 2
... 11 Travel Nurse across America has,achieved the ... from The Joint Commission. , ... national supplemental healthcare staffing,firm, recently underwent a thorough ... how staffing firms determine the qualifications,and competency of ...
... APFC ) today reported financial results for its fiscal 2008 ... We provide non-GAAP measures as a supplement to ... to the most directly,comparable GAAP measures is included in the accompanying ... , Quarter Ended September 30, ...
... Scientists in the clinic and the laboratory continue to ... breakthrough drugs. With tamoxifen,s discovery 30 years behind us, ... are studying zoledronic acid, aromatase inhibitors and monoclonal antibodies, ... at the CTRC-AACR San Antonio Breast Cancer Symposium. ...
... Federation for,Medical Research (AFMR) announces its full support of ... of Health and Human Services,secretary. Mr. Daschle will serve ... health care system. , ... the AFMR believes firmly that,improving clinical research in the ...
... Our Hands - Has Been Designed To Help Improve Patient ... Services In Local Communities , , ... its Community Health Partnership (CHP), It,s In Our Hands ... residents with local healthcare professionals and health resources in their ...
... Courage Center,s Transitional,Rehabilitation Program, which is licensed as ... the Stratis Health 2008-2011 Technical Assistance Group, a,learning collaborative ... is,supported by the federal Centers for Medicare & Medicaid ... Medicare Quality Improvement,Organization (QIO). , ...
Cached Medicine News:Health News:Travel Nurse Across America Awarded Certification From The Joint Commission 2Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 2Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 3Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 4Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 5Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 6Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 7Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 8Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 9Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 10Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 11Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 12Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 13Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 14Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 15Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 16Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 17Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 18Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 19Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 20Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 21Health News:American Pacific Reports Fiscal 2008 Results; Net Income Increases 80% 22Health News:Cancer drugs in the pipeline 2Health News:The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System 2Health News:The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System 3Health News:The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System 4Health News:Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care 2Health News:Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care 3Health News:Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care 4Health News:Courage Center Transitional Rehabilitation Program to Participate in Learning Collaborative With Stratis Health 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: